ruboxistaurin has been researched along with lysine in 1 studies
| Studies (ruboxistaurin) | Trials (ruboxistaurin) | Recent Studies (post-2010) (ruboxistaurin) | Studies (lysine) | Trials (lysine) | Recent Studies (post-2010) (lysine) |
|---|---|---|---|---|---|
| 203 | 29 | 56 | 37,449 | 622 | 11,213 |
| Protein | Taxonomy | ruboxistaurin (IC50) | lysine (IC50) |
|---|---|---|---|
| Cationic amino acid transporter 3 | Homo sapiens (human) | 158 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kumar, U; Lin, G; MacLeod, KM; McNeill, JH; Nagareddy, PR; Rajput, PS; Soliman, H | 1 |
1 other study(ies) available for ruboxistaurin and lysine
| Article | Year |
|---|---|
Selective inhibition of protein kinase C beta(2) attenuates inducible nitric oxide synthase-mediated cardiovascular abnormalities in streptozotocin-induced diabetic rats.
Topics: Animals; Aorta; Blood Glucose; Cardiovascular Diseases; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Enzyme Induction; Enzyme Inhibitors; Glucose; Indoles; Lysine; Male; Maleimides; Mannitol; Muscle, Smooth, Vascular; Myocytes, Cardiac; Nitric Oxide Synthase Type II; Protein Kinase C; Protein Kinase C beta; Rats; Rats, Wistar | 2009 |